SEB Asset Management AB Buys Shares of 319,201 The Cooper Companies, Inc. $COO

SEB Asset Management AB bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 319,201 shares of the medical device company’s stock, valued at approximately $22,823,000.

Several other hedge funds also recently modified their holdings of the business. Wellington Management Group LLP raised its holdings in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. Generation Investment Management LLP bought a new stake in Cooper Companies in the fourth quarter worth $233,539,000. Diamond Hill Capital Management Inc. increased its position in Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after buying an additional 2,720,594 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in Cooper Companies by 108.2% during the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after buying an additional 2,089,763 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on COO. Robert W. Baird reduced their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Finally, Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $81.85.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $71.71 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock’s 50-day moving average is $66.24 and its 200-day moving average is $72.52. The company has a market cap of $13.99 billion, a P/E ratio of 60.77, a P/E/G ratio of 1.87 and a beta of 0.84. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the firm earned $0.96 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.